Cutia Therapeutics (HKG:2487) recorded a revenue of 148.9 million from its commercialized products for the nine months ended Sept. 30, representing a year-on-year increase of 129.9%, a Thursday Hong Kong bourse filing said.
Cutia Therapeutics (HKG:2487) recorded a revenue of 148.9 million from its commercialized products for the nine months ended Sept. 30, representing a year-on-year increase of 129.9%, a Thursday Hong Kong bourse filing said.
Comments